Diversify Advisory Services
WST icon

Diversify Advisory Services’s West Pharmaceutical WST Stock Holding History

Diversify Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$372K Buy
970
+79
+9% +$27.9K 0.01% 1026
2026
Q2 		$295K Buy
+891
New +$272K ﹤0.01% 1060
2024
Q2 		– Sell
-686
Closed -$272K – 725
2024
Q1 		$272K Buy
+686
New +$254K 0.02% 550

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Diversify Advisory Services's WST Position: Q3 2026 in Review

Diversify Advisory Services increased its West Pharmaceutical (WST) stake by 8.9% in Q3 2026, buying an estimated $27.9K and bringing the position to 970 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #1026.

Diversify Advisory Services first reported a position in WST in Q1 2024 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Diversify Advisory Services held 970 shares of West Pharmaceutical worth $372K as of Q3 2026.
  • Diversify Advisory Services bought 79 West Pharmaceutical shares in Q3 2026, an estimated $27.9K.
  • West Pharmaceutical made up 0.01% of Diversify Advisory Services's portfolio in Q3 2026, its #1026 holding.
  • Diversify Advisory Services first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Diversify Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.